nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP1A2—chronic obstructive pulmonary disease	0.353	1	CbGaD
Methadone—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0369	0.0865	CbGbCtD
Methadone—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0369	0.0865	CbGbCtD
Methadone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0333	0.0781	CbGbCtD
Methadone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0306	0.0719	CbGbCtD
Methadone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0306	0.0719	CbGbCtD
Methadone—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0289	0.0679	CbGbCtD
Methadone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.028	0.0658	CbGbCtD
Methadone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.028	0.0658	CbGbCtD
Methadone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.025	0.0586	CbGbCtD
Methadone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0235	0.0552	CbGbCtD
Methadone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0232	0.0545	CbGbCtD
Methadone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0159	0.0373	CbGbCtD
Methadone—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0155	0.0363	CbGbCtD
Methadone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0151	0.0356	CbGbCtD
Methadone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0135	0.0317	CbGbCtD
Methadone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0132	0.031	CbGbCtD
Methadone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0125	0.0293	CbGbCtD
Methadone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00792	0.0186	CbGbCtD
Methadone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00748	0.0176	CbGbCtD
Methadone—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.00088	0.296	CrCbGaD
Methadone—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000437	0.00297	CcSEcCtD
Methadone—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000435	0.00296	CcSEcCtD
Methadone—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000434	0.00295	CcSEcCtD
Methadone—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00294	CcSEcCtD
Methadone—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00294	CcSEcCtD
Methadone—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.00043	0.00292	CcSEcCtD
Methadone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000429	0.00292	CcSEcCtD
Methadone—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000427	0.0029	CcSEcCtD
Methadone—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00289	CcSEcCtD
Methadone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000418	0.00284	CcSEcCtD
Methadone—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000415	0.00282	CcSEcCtD
Methadone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000415	0.00282	CcSEcCtD
Methadone—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000412	0.0028	CcSEcCtD
Methadone—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000408	0.00277	CcSEcCtD
Methadone—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000403	0.00274	CcSEcCtD
Methadone—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00272	CcSEcCtD
Methadone—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00272	CcSEcCtD
Methadone—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00272	CcSEcCtD
Methadone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000399	0.00271	CcSEcCtD
Methadone—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000399	0.00271	CcSEcCtD
Methadone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000396	0.00269	CcSEcCtD
Methadone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000395	0.00269	CcSEcCtD
Methadone—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000395	0.00268	CcSEcCtD
Methadone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000393	0.00267	CcSEcCtD
Methadone—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00267	CcSEcCtD
Methadone—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000391	0.00266	CcSEcCtD
Methadone—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000388	0.00264	CcSEcCtD
Methadone—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.00262	CcSEcCtD
Methadone—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00258	CcSEcCtD
Methadone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.00257	CcSEcCtD
Methadone—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.00257	CcSEcCtD
Methadone—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00255	CcSEcCtD
Methadone—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00255	CcSEcCtD
Methadone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000373	0.00253	CcSEcCtD
Methadone—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00252	CcSEcCtD
Methadone—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000368	0.0025	CcSEcCtD
Methadone—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00248	CcSEcCtD
Methadone—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00248	CcSEcCtD
Methadone—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000364	0.00247	CcSEcCtD
Methadone—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00244	CcSEcCtD
Methadone—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00244	CcSEcCtD
Methadone—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00243	CcSEcCtD
Methadone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000357	0.00243	CcSEcCtD
Methadone—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00241	CcSEcCtD
Methadone—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00239	CcSEcCtD
Methadone—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00235	CcSEcCtD
Methadone—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000345	0.00234	CcSEcCtD
Methadone—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000345	0.00234	CcSEcCtD
Methadone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000342	0.00232	CcSEcCtD
Methadone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.0023	CcSEcCtD
Methadone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000338	0.00229	CcSEcCtD
Methadone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00229	CcSEcCtD
Methadone—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.00227	CcSEcCtD
Methadone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000332	0.00226	CcSEcCtD
Methadone—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00225	CcSEcCtD
Methadone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.00225	CcSEcCtD
Methadone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000331	0.00225	CcSEcCtD
Methadone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00225	CcSEcCtD
Methadone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.00225	CcSEcCtD
Methadone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.00225	CcSEcCtD
Methadone—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00225	CcSEcCtD
Methadone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00221	CcSEcCtD
Methadone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00221	CcSEcCtD
Methadone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00221	CcSEcCtD
Methadone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000324	0.0022	CcSEcCtD
Methadone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.0022	CcSEcCtD
Methadone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000323	0.00219	CcSEcCtD
Methadone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.00216	CcSEcCtD
Methadone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000319	0.00216	CcSEcCtD
Methadone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.00216	CcSEcCtD
Methadone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000319	0.00216	CcSEcCtD
Methadone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00213	CcSEcCtD
Methadone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000313	0.00212	CcSEcCtD
Methadone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00212	CcSEcCtD
Methadone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00212	CcSEcCtD
Methadone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000312	0.00212	CcSEcCtD
Methadone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000312	0.00212	CcSEcCtD
Methadone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00211	CcSEcCtD
Methadone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00211	CcSEcCtD
Methadone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.00209	CcSEcCtD
Methadone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00208	CcSEcCtD
Methadone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000305	0.00208	CcSEcCtD
Methadone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00205	CcSEcCtD
Methadone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.00204	CcSEcCtD
Methadone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.00204	CcSEcCtD
Methadone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00202	CcSEcCtD
Methadone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00202	CcSEcCtD
Methadone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000296	0.00201	CcSEcCtD
Methadone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00201	CcSEcCtD
Methadone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.00201	CcSEcCtD
Methadone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.00199	CcSEcCtD
Methadone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.00198	CcSEcCtD
Methadone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00198	CcSEcCtD
Methadone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00196	CcSEcCtD
Methadone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00196	CcSEcCtD
Methadone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00195	CcSEcCtD
Methadone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.00195	CcSEcCtD
Methadone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00192	CcSEcCtD
Methadone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00192	CcSEcCtD
Methadone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00192	CcSEcCtD
Methadone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00191	CcSEcCtD
Methadone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000279	0.0019	CcSEcCtD
Methadone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00188	CcSEcCtD
Methadone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000277	0.00188	CcSEcCtD
Methadone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00188	CcSEcCtD
Methadone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00185	CcSEcCtD
Methadone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00185	CcSEcCtD
Methadone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00185	CcSEcCtD
Methadone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00185	CcSEcCtD
Methadone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00185	CcSEcCtD
Methadone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00182	CcSEcCtD
Methadone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00181	CcSEcCtD
Methadone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000266	0.00181	CcSEcCtD
Methadone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00179	CcSEcCtD
Methadone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00179	CcSEcCtD
Methadone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00178	CcSEcCtD
Methadone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00178	CcSEcCtD
Methadone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.00178	CcSEcCtD
Methadone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00178	CcSEcCtD
Methadone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00178	CcSEcCtD
Methadone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.00177	CcSEcCtD
Methadone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00177	CcSEcCtD
Methadone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00177	CcSEcCtD
Methadone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00175	CcSEcCtD
Methadone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00175	CcSEcCtD
Methadone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00173	CcSEcCtD
Methadone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00172	CcSEcCtD
Methadone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00172	CcSEcCtD
Methadone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00171	CcSEcCtD
Methadone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00171	CcSEcCtD
Methadone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00171	CcSEcCtD
Methadone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00171	CcSEcCtD
Methadone—Clotrimazole—CYP1A2—chronic obstructive pulmonary disease	0.000251	0.0846	CrCbGaD
Methadone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.0017	CcSEcCtD
Methadone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00169	CcSEcCtD
Methadone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00169	CcSEcCtD
Methadone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000249	0.00169	CcSEcCtD
Methadone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00168	CcSEcCtD
Methadone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00168	CcSEcCtD
Methadone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00168	CcSEcCtD
Methadone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00168	CcSEcCtD
Methadone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00168	CcSEcCtD
Methadone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00168	CcSEcCtD
Methadone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00167	CcSEcCtD
Methadone—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00165	CcSEcCtD
Methadone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00165	CcSEcCtD
Methadone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00162	CcSEcCtD
Methadone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00162	CcSEcCtD
Methadone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00162	CcSEcCtD
Methadone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00159	CcSEcCtD
Methadone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00159	CcSEcCtD
Methadone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000234	0.00159	CcSEcCtD
Methadone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00159	CcSEcCtD
Methadone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00158	CcSEcCtD
Methadone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00156	CcSEcCtD
Methadone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.00155	CcSEcCtD
Methadone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000229	0.00155	CcSEcCtD
Methadone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00153	CcSEcCtD
Methadone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00153	CcSEcCtD
Methadone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00152	CcSEcCtD
Methadone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00151	CcSEcCtD
Methadone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000221	0.0015	CcSEcCtD
Methadone—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.00022	0.0741	CrCbGaD
Methadone—Modafinil—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.0739	CrCbGaD
Methadone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00148	CcSEcCtD
Methadone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00148	CcSEcCtD
Methadone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00147	CcSEcCtD
Methadone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00147	CcSEcCtD
Methadone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00146	CcSEcCtD
Methadone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00145	CcSEcCtD
Methadone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00145	CcSEcCtD
Methadone—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00144	CcSEcCtD
Methadone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00143	CcSEcCtD
Methadone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00143	CcSEcCtD
Methadone—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	0.000207	0.0698	CrCbGaD
Methadone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000206	0.0014	CcSEcCtD
Methadone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.0014	CcSEcCtD
Methadone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00138	CcSEcCtD
Methadone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00138	CcSEcCtD
Methadone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00136	CcSEcCtD
Methadone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00136	CcSEcCtD
Methadone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00136	CcSEcCtD
Methadone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00136	CcSEcCtD
Methadone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00136	CcSEcCtD
Methadone—Headache—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00136	CcSEcCtD
Methadone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00136	CcSEcCtD
Methadone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00135	CcSEcCtD
Methadone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00135	CcSEcCtD
Methadone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00135	CcSEcCtD
Methadone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00134	CcSEcCtD
Methadone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00134	CcSEcCtD
Methadone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00133	CcSEcCtD
Methadone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.0013	CcSEcCtD
Methadone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00129	CcSEcCtD
Methadone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00129	CcSEcCtD
Methadone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00129	CcSEcCtD
Methadone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00129	CcSEcCtD
Methadone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00129	CcSEcCtD
Methadone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00129	CcSEcCtD
Methadone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00128	CcSEcCtD
Methadone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00126	CcSEcCtD
Methadone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000185	0.00126	CcSEcCtD
Methadone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00124	CcSEcCtD
Methadone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00122	CcSEcCtD
Methadone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00121	CcSEcCtD
Methadone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00119	CcSEcCtD
Methadone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00117	CcSEcCtD
Methadone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00117	CcSEcCtD
Methadone—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	0.00017	0.0574	CrCbGaD
Methadone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00115	CcSEcCtD
Methadone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.00114	CcSEcCtD
Methadone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00113	CcSEcCtD
Methadone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00111	CcSEcCtD
Methadone—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	0.000159	0.0537	CrCbGaD
Methadone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00107	CcSEcCtD
Methadone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00106	CcSEcCtD
Methadone—Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.0519	CrCbGaD
Methadone—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00104	CcSEcCtD
Methadone—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.0514	CrCbGaD
Methadone—Propiomazine—HTR2A—chronic obstructive pulmonary disease	0.00015	0.0505	CrCbGaD
Methadone—Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.05	CrCbGaD
Methadone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.001	CcSEcCtD
Methadone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000966	CcSEcCtD
Methadone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000959	CcSEcCtD
Methadone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000937	CcSEcCtD
Methadone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000936	CcSEcCtD
Methadone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000931	CcSEcCtD
Methadone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000917	CcSEcCtD
Methadone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000904	CcSEcCtD
Methadone—Trimipramine—HTR2A—chronic obstructive pulmonary disease	0.000131	0.0441	CrCbGaD
Methadone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000885	CcSEcCtD
Methadone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000863	CcSEcCtD
Methadone—Promethazine—HTR2A—chronic obstructive pulmonary disease	0.000126	0.0425	CrCbGaD
Methadone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000852	CcSEcCtD
Methadone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000852	CcSEcCtD
Methadone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000838	CcSEcCtD
Methadone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000831	CcSEcCtD
Methadone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000823	CcSEcCtD
Methadone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000812	CcSEcCtD
Methadone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000775	CcSEcCtD
Methadone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00077	CcSEcCtD
Methadone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00074	CcSEcCtD
Methadone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000739	CcSEcCtD
Methadone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000738	CcSEcCtD
Methadone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000734	CcSEcCtD
Methadone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000728	CcSEcCtD
Methadone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000702	CcSEcCtD
Methadone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000696	CcSEcCtD
Methadone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000696	CcSEcCtD
Methadone—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000677	CcSEcCtD
Methadone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.000673	CcSEcCtD
Methadone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.000673	CcSEcCtD
Methadone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.000627	CcSEcCtD
Methadone—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.99e-05	0.000611	CcSEcCtD
Methadone—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.87e-05	0.000602	CcSEcCtD
Methadone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.58e-05	0.000583	CcSEcCtD
Methadone—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.000563	CcSEcCtD
Methadone—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.97e-05	0.000541	CcSEcCtD
Methadone—Rash—Prednisone—chronic obstructive pulmonary disease	7.9e-05	0.000537	CcSEcCtD
Methadone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.9e-05	0.000536	CcSEcCtD
Methadone—Headache—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.000533	CcSEcCtD
Methadone—Nausea—Prednisone—chronic obstructive pulmonary disease	7.45e-05	0.000506	CcSEcCtD
Methadone—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.78e-05	0.000393	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.77e-05	0.000393	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.74e-05	0.000388	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.74e-05	0.000387	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	2.73e-05	0.000386	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	2.72e-05	0.000385	CbGpPWpGaD
Methadone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.7e-05	0.000383	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.66e-05	0.000377	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.66e-05	0.000377	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.66e-05	0.000376	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.63e-05	0.000372	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.55e-05	0.000361	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.53e-05	0.000358	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.52e-05	0.000357	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.52e-05	0.000356	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.52e-05	0.000356	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.52e-05	0.000356	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.49e-05	0.000352	CbGpPWpGaD
Methadone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.48e-05	0.000352	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.47e-05	0.00035	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.43e-05	0.000344	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.39e-05	0.000338	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.39e-05	0.000338	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.37e-05	0.000335	CbGpPWpGaD
Methadone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.000333	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.35e-05	0.000333	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.35e-05	0.000333	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.32e-05	0.000328	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.31e-05	0.000326	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.29e-05	0.000324	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.28e-05	0.000322	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.25e-05	0.000318	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.25e-05	0.000318	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.22e-05	0.000314	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.21e-05	0.000313	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.14e-05	0.000303	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.14e-05	0.000302	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.13e-05	0.000302	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.12e-05	0.000299	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.1e-05	0.000297	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.1e-05	0.000297	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000296	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.08e-05	0.000294	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.07e-05	0.000293	CbGpPWpGaD
Methadone—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.07e-05	0.000292	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.06e-05	0.000292	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.06e-05	0.000291	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.06e-05	0.000291	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.01e-05	0.000285	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.01e-05	0.000284	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.99e-05	0.000281	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.95e-05	0.000275	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.95e-05	0.000275	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.93e-05	0.000273	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.93e-05	0.000273	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.93e-05	0.000273	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.92e-05	0.000272	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.91e-05	0.000271	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.91e-05	0.000271	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.9e-05	0.000269	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.89e-05	0.000268	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.88e-05	0.000266	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.87e-05	0.000264	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.87e-05	0.000264	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.83e-05	0.000259	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000257	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.81e-05	0.000256	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.77e-05	0.000251	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.76e-05	0.000249	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.74e-05	0.000247	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.000243	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.71e-05	0.000242	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.7e-05	0.000241	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.67e-05	0.000237	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.67e-05	0.000236	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.67e-05	0.000236	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.65e-05	0.000233	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.64e-05	0.000233	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.61e-05	0.000227	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.6e-05	0.000227	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.6e-05	0.000227	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.58e-05	0.000224	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.00022	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.55e-05	0.000219	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.53e-05	0.000217	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.53e-05	0.000216	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.000216	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.5e-05	0.000213	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.5e-05	0.000213	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.49e-05	0.000211	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.49e-05	0.000211	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.49e-05	0.000211	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-05	0.000211	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.48e-05	0.000209	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.47e-05	0.000208	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.45e-05	0.000206	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.44e-05	0.000203	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.43e-05	0.000202	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.41e-05	0.0002	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.000198	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000197	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.39e-05	0.000197	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.38e-05	0.000196	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.000195	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.36e-05	0.000193	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.36e-05	0.000192	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.34e-05	0.00019	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.31e-05	0.000186	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.3e-05	0.000185	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000181	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.27e-05	0.00018	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.00018	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.26e-05	0.000179	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.26e-05	0.000178	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.26e-05	0.000178	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.25e-05	0.000176	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000176	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.24e-05	0.000175	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.000175	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000172	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.21e-05	0.000172	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.21e-05	0.000171	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.000168	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.19e-05	0.000168	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.16e-05	0.000164	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.15e-05	0.000163	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.15e-05	0.000163	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.15e-05	0.000162	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.14e-05	0.000161	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.14e-05	0.000161	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.000159	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.000157	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.1e-05	0.000156	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.000155	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	0.000154	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000154	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.05e-05	0.000148	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000147	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.04e-05	0.000147	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000146	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.000146	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000145	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.03e-05	0.000145	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000145	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	0.000144	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.000144	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.01e-05	0.000143	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.01e-05	0.000143	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.97e-06	0.000141	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.94e-06	0.000141	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.9e-06	0.00014	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.62e-06	0.000136	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.52e-06	0.000135	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	9.51e-06	0.000135	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.48e-06	0.000134	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.45e-06	0.000134	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.34e-06	0.000132	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.33e-06	0.000132	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.26e-06	0.000131	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.25e-06	0.000131	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.19e-06	0.00013	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.12e-06	0.000129	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.1e-06	0.000129	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.09e-06	0.000129	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.98e-06	0.000127	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.78e-06	0.000124	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.76e-06	0.000124	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.74e-06	0.000124	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.73e-06	0.000124	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.66e-06	0.000123	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.61e-06	0.000122	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.59e-06	0.000122	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.52e-06	0.000121	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.43e-06	0.000119	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.31e-06	0.000118	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	8.26e-06	0.000117	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.07e-06	0.000114	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.06e-06	0.000114	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.04e-06	0.000114	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.02e-06	0.000114	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.9e-06	0.000112	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	7.9e-06	0.000112	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.79e-06	0.00011	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.69e-06	0.000109	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.68e-06	0.000109	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.66e-06	0.000108	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.61e-06	0.000108	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.61e-06	0.000108	CbGpPWpGaD
Methadone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.5e-06	0.000106	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.47e-06	0.000106	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.29e-06	0.000103	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.17e-06	0.000101	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.16e-06	0.000101	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.11e-06	0.000101	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.07e-06	0.0001	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.01e-06	9.92e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.99e-06	9.89e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.85e-06	9.7e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.81e-06	9.64e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.79e-06	9.61e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.76e-06	9.57e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.72e-06	9.51e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.68e-06	9.46e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.63e-06	9.38e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.59e-06	9.32e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.55e-06	9.27e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.53e-06	9.24e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.48e-06	9.17e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.24e-06	8.84e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.19e-06	8.76e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.16e-06	8.72e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	6.11e-06	8.64e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.1e-06	8.63e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.07e-06	8.59e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.01e-06	8.5e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.99e-06	8.48e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.97e-06	8.45e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.89e-06	8.34e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.84e-06	8.27e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.71e-06	8.08e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.64e-06	7.98e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.62e-06	7.95e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.58e-06	7.9e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.53e-06	7.83e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.29e-06	7.49e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	5.17e-06	7.32e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.16e-06	7.31e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.08e-06	7.19e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.98e-06	7.05e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.95e-06	7e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.95e-06	7e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.69e-06	6.63e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.62e-06	6.54e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.62e-06	6.53e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.53e-06	6.41e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.5e-06	6.38e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.41e-06	6.25e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.31e-06	6.1e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.31e-06	6.1e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.24e-06	6.01e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.21e-06	5.96e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.18e-06	5.92e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.08e-06	5.78e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.06e-06	5.75e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.03e-06	5.7e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.83e-06	5.42e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.6e-06	5.09e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.44e-06	4.87e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.78e-06	3.93e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.65e-06	3.76e-05	CbGpPWpGaD
